Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2
Open Access
- 1 April 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (16) , 10882-10894
- https://doi.org/10.1074/jbc.272.16.10882
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancerInternational Journal of Cancer, 1995
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- Cyclin-Dependent Kinases: CAK-handed kinase activationCurrent Biology, 1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Regulation of ribosomal protein S6 kinase in human mammary tumor cells: Effect of estrogen, growth factors and phorbol esterCellular and Molecular Life Sciences, 1988
- Mode of estrogen action on cell proliferation in CAMA‐1 cells: II. Sensitivity of G1 phase populationJournal of Cellular Biochemistry, 1987
- Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogensEuropean Journal of Cancer and Clinical Oncology, 1983
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896